Ultragenyx Pharmaceutical | RARE - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Acadia Pharmaceuticals USD 1.22B 128.53M 2026-06
Agios Pharmaceuticals USD 717.67M 117.18M 2026-06
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
BioCryst Pharmaceuticals USD 484.68M 111.06M 2026-06
BioMarin Pharmaceutical USD 3.92B 50.99M 2026-09
Immunic USD 188.76M 165.89M 2026-03
Insmed USD 1.71B 72.59M 2026-09
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Kyowa Hakko Kirin JPY 482.59B 35.17B 2026-09
MacroGenics USD 321.69M 139.16M 2026-06
Moderna USD 5.82B 45M 2026-06
Neurocrine Biosciences USD 2.01B 370.7M 2026-09
PTC Therapeutics USD 2.54B 79.58M 2026-09
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Sarepta Therapeutics USD 2.22B 86.05M 2026-06
Ultragenyx Pharmaceutical USD 544M 62M 2026-09
Vertex Pharmaceuticals USD 11.69B 857.4M 2026-09